Clinical Trials Logo

Filter by:
NCT ID: NCT02457559 Completed - Clinical trials for Relapsed/Refractory B-cell Malignancies

Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies

Start date: September 10, 2015
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to determine the long-term safety and tolerability of tirabrutinib in adults with relapsed/refractory B-cell malignancy who have tolerated and achieved stable disease or improved with tirabrutinib treatment while enrolled in a prior (parent study) tirabrutinib study (NCT01659255). The dosing regimen will be based on the prior dosing regimen from the parent study.

NCT ID: NCT02457494 Completed - HIV Clinical Trials

Kidney Stone Risk Factors in Patients Infected With HIV

CALVIH
Start date: May 2015
Phase:
Study type: Observational

The purpose of this study is to define the cause of renal stones and the risk pattern for recurrence of renal stones episodes (any kind of stones) in HIV1 patients.

NCT ID: NCT02457052 Completed - Clinical trials for Deglutition Disorders

Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders

DATP-DEG
Start date: October 2014
Phase: N/A
Study type: Interventional

When the seat is a vehicle for disabled person, postural adaptation methodology is known and, on prescription, there is possibility of financial support for technical posture assists. For people who use a standard seat, a chair for example, there is no satisfactory existing hardware. A transportable customisable and scalable sitting positioning device (DATP device), to be placed on a standard seat, is a solution that might fit in the home, in specialized foster homes or in institutions for the elderly. Such a device has been developed but earnings on swallowing disorders have to be validated.

NCT ID: NCT02456753 Completed - Clinical trials for Ultrasonography, Prenatal

Assesment by Ultrasonography of the Perineal-cephalic Distance

ECHOTRANS
Start date: September 2012
Phase: N/A
Study type: Observational

The practice of ultrasounds increases in delivery rooms every year. Indeed, this method can help to visualize elements that may not be observable after clinical examination. Moreover, it is known that a fetal head engagement can lead to an instrumental extraction and in case of error, which happens in some cases, fetal and maternal risks are possible. These elements led to the investigators' hypothesis which is that a trans-perineal ultrasonography may facilitate the evaluation of a clinical fetal head engagement in case of doubt.

NCT ID: NCT02456272 Completed - Otosclerosis Clinical Trials

Hearing Aid Versus Surgical Rehabilitation as Treatment of Otosclerosis: Pilot Study

PARCO
Start date: September 2015
Phase: N/A
Study type: Interventional

This is a French pilot study in the Toulouse University Hospital that will include a minimum of 30 patients with proven unilateral or asymmetric otosclerosis. Each one will receive a hearing aid for a minimum of 2 months and then undergo otosclerosis surgery.

NCT ID: NCT02455375 Completed - Clinical trials for Hemorrhagic Fever With Renal Syndrome

Diagnostic of Puumala Virus Infection in France

HANTADIAG
Start date: July 2015
Phase:
Study type: Observational

Routine Puumala virus (PUUV) infection diagnosis is performed using serological commercial kits of which performances have not been established in real life, which use recombinant protein from strains from Central or North Europe. Molecular diagnostic of these infection is not the rule. Consequently the objectives of the project are to evaluate the performances of the serological commercial assays in real life in France and to assess the use of urine versus plasma for the molecular diagnostic of this infection.

NCT ID: NCT02455284 Completed - Clinical trials for Neurological Diseases

In Vivo and ex Vivo Validation of MR Tractography of Brain White Matter Tracts - FIBRATLAS II-III

FIBRATLAS
Start date: October 2015
Phase: N/A
Study type: Interventional

White matter tracts connect cortical areas to other parts of the cortex, to basal ganglia and to the brain stem and spinal cord. These tracts form the internal part of the brain and transmit the nervous impulses. Changes in brain white matter may serve as biomarkers for numerous neurological diseases. Diffusion Weighted Imaging (DWI) is a non-invasive MRI (Magnetic Resonance Imaging) technique providing information on white matter tracts (tractography) by studying water diffusion. Since it is based on complex mathematical models that only indirectly evaluates the underlying anatomy, tractography need to be validated before being used for research and clinical purposes. Several validation techniques were previously proposed, none of them being fully convincing in human.

NCT ID: NCT02455232 Completed - Hemiplegia Clinical Trials

Determine the Main Muscle Participant in the Deformation of the Elbow in Hemiplegic Patients

FLEXELBOW
Start date: May 2015
Phase: N/A
Study type: Interventional

The aim of this study is to determinate what are the main muscles regularly involved in the spastic pattern in flexion of the elbow using the selective motor nerve blocks of the elbow flexors. Three selective motor block nerves will be carry out in order to assess the gain of the range of motion (passive and active) of the elbow after each Motor Block Nerve.

NCT ID: NCT02455089 Completed - Lupus Erythematosus Clinical Trials

Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

GADD34-LES
Start date: June 2015
Phase: N/A
Study type: Interventional

Given that GADD34 has been described as a potential key regulator of pro-inflammatory cytokine production in human and elevated blood marker in SLE patients, this study aim to prove that the GADD34 RNA level in mononuclear blood cells can be used as a prognostic marker to assess the risk of SLE flare.

NCT ID: NCT02454972 Completed - Clinical trials for Advanced Solid Tumors

Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors

Start date: August 25, 2015
Phase: Phase 2
Study type: Interventional

Multicenter, open-label, exploratory, phase II clinical trial to evaluate the efficacy and safety of PM01183 in previously treated patients with advanced solid tumors